AI bias seeps into algorithms and models that affect clinical and health insurance decisions as well as clinical trials. InformationWeek speaks to experts that discuss how to avoid these discriminatory errors.
This article discusses AI uses cases, in drug development and interviews the CEO of BioPhy and provides insights on being an entrepreneur, and guiding our youth.
There's an intentional method to drug naming, according to the American Medical Association. BioPhy CEO Dr. Dave Latshaw breaks down what goes into it.
How are prescription drugs named? A drug development expert shares the process wfin.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wfin.com Daily Mail and Mail on Sunday newspapers.
General Catalyst just announced its plans to acquire Summa Health, an Ohio-based health system. Leaders from across the healthcare industry aren't sure how the deal will play out, given the novel nature of the deal and the involvement of one of the country’s most prominent VC firms.